Vimarsana
Biggest News Aggregation in the World

Page 3 - Digital Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Digital Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Digital Pharma Today - Breaking & Trending Today

AstraZeneca's COVID-19 vaccine faces distrust in Europe, even as it gets rave reviews in neighboring UK, survey finds - Vimarsana News

AstraZeneca's COVID-19 vaccine faces distrust in Europe, even as it gets rave reviews in neighboring UK, survey finds

AstraZeneca’s coronavirus vaccine is facing a wave of mistrust in Europe—a striking difference from its stellar reputation in the U.K. While 81% of Britons believe the AZ vaccine is safe, which is on par with similar 79% of U.K. citizens who trust of the Pfizer vaccine, only 43% of Germans and 33% of French citizens consider it safe, accoriding to a surveyed by YouGov.

Seven European countries clamp down on AstraZeneca COVID-19 vaccine as safety worries threaten rollout - Vimarsana News

Seven European countries clamp down on AstraZeneca COVID-19 vaccine as safety worries threaten rollout

AstraZeneca’s COVID-19 vaccine rollout has gotten off to a rocky start in Europe. First, a supply shortfall triggered a public back-and-forth between executives and government officials. Then, several countries raised efficacy doubts for people over 65. Now some countries are raising safety concerns.

Johnson & Johnson to sell another 100M coronavirus vaccine doses to U.S., taking America's supply to 800M doses: reports - Vimarsana News

Johnson & Johnson to sell another 100M coronavirus vaccine doses to U.S., taking America's supply to 800M doses: reports

Mar 10, 2021 10:24am Johnson & Johnson will sell another 100 million COVID-19 vaccine doses to the U.S., according to reports.(J&J) One year ago this week, the COVID-19 pandemic hit home with Americans when Tom Hanks revealed he had tested positive and the NBA postponed its season indefinitely. Things have changed mightily since then: A national vaccine rollout is gaining steam, and the U.S. is inking yet another huge supply deal. The Biden administration is purchasing another 100 million doses of the one-dose shot from Johnson & Johnson, according to media reports. The vaccine is jus...

PatientPoint merges with Outcome Health, combining networks and sunsetting the scandal-tainted Outcome brand - Vimarsana News

PatientPoint merges with Outcome Health, combining networks and sunsetting the scandal-tainted Outcome brand

Mar 10, 2021 9:35am PatientPoint and Outcome Health are merging to form the new PatientPoint point-of-care network and company. (Alpha Stock Image) After enduring a turbulent few years, point-of-care advertising and marketing company Outcome Health is getting a makeover, thanks to a merger. PatientPoint is merging with Outcome to create PatientPoint Health Technologies point-of-care network, and in the process it's retiring the Outcome name. The combined company will be led by PatientPoint executives and CEO Mike Collette. Outcome Health CEO Matt McNally and chief operating officer Nandin...

NantKwest starts dosing in subcutaneous, sublingual and oral COVID-19 vaccine trials - Vimarsana News

NantKwest starts dosing in subcutaneous, sublingual and oral COVID-19 vaccine trials

Patrick Soon-Shiong, M.D., executive chairman of ImmunityBio and NantKwest (NantKwest) ImmunityBio and NantKwest have begun dosing participants with subcutaneous, sublingual and oral COVID-19 vaccine candidates. The trials are designed to determine which combination of routes of administration holds the most potential. While a clutch of COVID-19 vaccines are now in commercial use around the world, the potential for the coronavirus to become a pathogen that continues to circulate for years means there may be a long-term opportunity for prophylactics. ImmunityBio and NantKwest are part of a gro...